UCI-HVB WAR. PUT 22 GS7/ DE000HB0W658 /
5/24/2022 9:45:02 PM | Chg.-0.0100 | Bid9:52:41 PM | Ask9:52:41 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.5900EUR | -1.67% | 0.5500 Bid Size: 6,000 |
0.6700 Ask Size: 6,000 |
Glaxosmithkline PLC ... | 15.50 GBP | 12/14/2022 | Put |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...